Medley 发表于 2025-3-23 13:11:03

http://reply.papertrans.cn/1/95/9416/9416-11.png

规范就好 发表于 2025-3-23 16:34:27

Submitted on: 16 February 2012.
Revised on: 05 May 2012.
Accepted on: 05 June 2012.

___________________European Urology Oncology---ELSEVIER

菊花 发表于 2025-3-23 21:20:55

Submitted on: 16 April 2012.
Revised on: 10 June 2012.
Accepted on: 17 July 2012.

___________________European Urology Oncology---ELSEVIER

母猪 发表于 2025-3-23 22:33:27

http://reply.papertrans.cn/1/95/9416/9416-14.png

Cpr951 发表于 2025-3-24 03:43:02

http://reply.papertrans.cn/1/95/9416/9416-15.png

FAZE 发表于 2025-3-24 10:00:34

Submitted on: 09 September 1998.
Revised on: 22 December 1998.
Accepted on: 16 January 1999.

___________________European Urology Oncology---ELSEVIER

斜 发表于 2025-3-24 12:45:03

http://reply.papertrans.cn/1/95/9416/9416-17.png

alliance 发表于 2025-3-24 15:34:49

Submitted on: 02 June 2002.
Revised on: 27 June 2002.
Accepted on: 11 August 2002.

___________________European Urology Oncology---ELSEVIER

Flirtatious 发表于 2025-3-24 22:14:24

Submitted on: 07 July 2007.
Revised on: 05 August 2007.
Accepted on: 26 September 2007.

___________________European Urology Oncology---ELSEVIER

infringe 发表于 2025-3-24 23:50:40

Submitted on: 24 September 2007.
Revised on: 07 November 2007.
Accepted on: 11 December 2007.

___________________European Urology Oncology---ELSEVIER
页: 1 [2] 3 4
查看完整版本: SCIE期刊European Urology Oncology 2024/2025影响因子:8.337 (EUR UROL ONCOL) (NULL). (UROLOGY & NEPHROLOGY)(泌尿科和肾病学)Science Cit